SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-027881
Filing Date
2023-08-11
Accepted
2023-08-11 17:11:48
Documents
62
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1183210
2 ex31-1.htm EX-31.1 21148
3 ex31-2.htm EX-31.2 21090
4 ex32.htm EX-32 10205
  Complete submission text file 0001493152-23-027881.txt   6052033

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE envb-20230630.xsd EX-101.SCH 50177
6 XBRL CALCULATION FILE envb-20230630_cal.xml EX-101.CAL 53191
7 XBRL DEFINITION FILE envb-20230630_def.xml EX-101.DEF 193834
8 XBRL LABEL FILE envb-20230630_lab.xml EX-101.LAB 396296
9 XBRL PRESENTATION FILE envb-20230630_pre.xml EX-101.PRE 301021
56 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1020223
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 231165158
SIC: 2834 Pharmaceutical Preparations